Drug Interactions : BPC-157's interaction with nitric oxide pathways and growth hormone receptors raises concerns about interference with medications (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), anticoagulants, and hormonal therapies)
had a question about storage and support got back to me same day
It protects the skin from environmental damage, brightens hyperpigmentation, evens out the skin tone, and stimulates collagen production
At a glance Direct interaction data / none published in human trials as of May 2026 BPC-157 primary mechanism / nitric oxide system modulation, angiogenesis, and GI cytoprotection Ashwagandha primary mechanism / HPA-axis modulation, cortisol reduction, withanolide-driven adaptogenesis Overlap concern / both influence the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes Suggested dose separation / 30 to 60 minutes between oral ashwagandha and oral BPC-157 Monitoring labs / TSH, free T4, morning cortisol at baseline and every 8 to 12 weeks Ashwagandha cortisol reduction / 30.5% decrease in serum cortisol vs
